Comparing Clinical Outcomes and Costs for Different Treatment Intensification Approaches in Patients with Type 2 Diabetes Uncontrolled On Basal Insulin: Adding Glucagon-Like Peptide 1 Receptor Agonists Versus Adding Rapid-Acting Insulin or Increasing Basal Insulin Dose-Reference-Cited by-同舟云学术

Comparing Clinical Outcomes and Costs for Different Treatment Intensification Approaches in Patients with Type 2 Diabetes Uncontrolled On Basal Insulin: Adding Glucagon-Like Peptide 1 Receptor Agonists Versus Adding Rapid-Acting Insulin or Increasing Basal Insulin Dose

Published:2017-11 Issue:11 Volume:23 Page:1316-1324
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Levin Philip,Fan Tao,Song Xue,Nero Damion,Davis Brian,Chu Bong-Chul

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. Standards of Medical Care in Diabetes–2017;American Diabetes Association;Diabetes Care,2016

3. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis;Eng;Lancet,2014

4. Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature;Balena;Diabetes Obes Metab,2013

5. Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis;Charbonnel;J Diabetes Complications,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide ‐1 receptor agonists: A narrative review and proposed clinical approach;Diabetes, Obesity and Metabolism;2022-03-24

2. Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies;BMJ Open Diabetes Research & Care;2021-08

3. Underutilization of insulin and better metabolic control. A NOVA clinic experience;Revista da Associação Médica Brasileira;2020-03

4. Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis;Journal of Clinical & Translational Endocrinology;2020-03

5. Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study;BMJ Open Diabetes Research & Care;2019-11